Jack Burns, Adam Subber, Dan Sullivan, and Paul Delaney of Cresa Boston represented Biomeasure, Inc., a wholly owned subsidiary of Ipsen, which is relocating to 650 East Kendall St. Ipsen, a global specialty care pharmaceutical company with headquarters in Paris, is moving its U.S. research and development operations to be closer to leading hospitals, universities, and biotech companies. The company currently has operations at 27 Maple St. in Milford. Ipsen signed an 11-year lease for 63,000 s/f in a 282,000 s/f, class A building, where it will occupy the entire second floor and a portion of the fourth floor. The move-in date is projected for mid-2014. The landlord, BioMed Realty Trust Inc., was represented by Steven Purpura and Eric Smith of Richards Barry Joyce & Partners.
"We are very excited about expanding our research and development efforts to Cambridge, a leading hub in biotechnology research," said Cynthia Sylvestre, president, Biomeasure and vice president and Milford site head, Ipsen. "This move puts our research capabilities in the center of Kendall Sq., one of the preeminent life science communities in the world, including prominent hospital centers, medical schools, biotech companies, and universities."
Cresa LLC, one of the nation's largest corporate real estate advisory firms exclusively representing tenants, is headquartered in Boston.
Cresa is an international corporate real estate advisory firm that exclusively represents tenants and specializes in the delivery of fully integrated real estate services, including: transaction management, project management, strategic planning, workforce and location planning, subleases and dispositions, portfolio/lease administration, capital markets, sustainability, industrial/supply chain, and facilities management.